Vagus Nerve Stimulation for Neuromodulation
(VNS-EPS Trial)
Trial Summary
What is the purpose of this trial?
This trial uses a device to send electrical pulses to the ear to affect heartbeats. It targets healthy people already having a heart study to see how this stimulation changes their heart's electrical signals.
Research Team
Stavros E Mountantonakis, MD
Principal Investigator
Northwell Health
Eligibility Criteria
This trial is for individuals needing an electrophysiological study (EPS) to check their heart's electrical system or to investigate rapid heartbeats. It's not open to those who've had previous EPS with ablation, known conduction issues in the heart, are pregnant, have certain cardiovascular diseases, a history of vagotomy, skin conditions on the tragus, or active implanted medical devices.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Auricular Vagal Nerve Stimulation (Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwell Health
Lead Sponsor
Michael Dowling
Northwell Health
Chief Executive Officer since 2002
Bachelor's and Master's degrees from University College Cork, Ireland
Dr. David Battinelli
Northwell Health
Chief Medical Officer since 2022
MD from Georgetown University School of Medicine
University of Oklahoma
Collaborator
Dr. Scott Rollins
University of Oklahoma
Chief Executive Officer since 2016
PhD in Immunology from the University of Oklahoma
Dr. Ondria Gleason
University of Oklahoma
Chief Medical Officer
MD from the University of Oklahoma College of Medicine